What is the best imaging modality for detecting early osteomyelitis?
Which of the following is a primarily RNA based technique?
Investigation of choice for leptomeningeal carcinomatosis:
What is the imaging modality of choice for localizing neuroendocrine tumors?
Substance used for PET scan is
Tc-labeled RBCs are used for all except:
Two transgenic plants were genetically engineered using Recombinant DNA technology. One plant was transformed using a plasmid vector with GFP (Green Fluorescent Protein) gene and another plant was transformed with a complete Luciferase bioluminescent system (including luciferase gene and luciferin substrate availability). Which of these two plants will glow spontaneously in the dark?
Radiopharmaceutical used for phagocyte study scan:
Match the following: A) Caplan syndrome- 1) Found first in coal worker B) Asbestosis- 2) Upper lobe predominance C) Mesothelioma- 3) Involves lower lobe D) Sarcoidosis- 4) Pleural effusion is seen
Which one of the following hepatic lesions can be diagnosed with high accuracy by using nuclear imaging?
Explanation: ***MRI*** - **Magnetic Resonance Imaging (MRI)** is considered the **gold standard** for detecting early osteomyelitis due to its excellent soft tissue contrast and ability to visualize **bone marrow edema**, which is an early sign of infection. - It can identify changes within **3-5 days** of infection onset, much earlier than other modalities. *CT scan* - While useful for showing **bone destruction**, cortical integrity, and sequestra, **CT scans** are less sensitive than MRI for detecting early marrow edema. - Its ability to diagnose osteomyelitis is usually delayed until significant **bony changes** have occurred, typically around 1-2 weeks. *X-ray* - **Plain radiographs** are often the initial imaging study but are **insensitive** for early osteomyelitis, showing changes only after 10-14 days or more. - Early findings on X-rays can be subtle, such as **periosteal elevation** or **soft tissue swelling**, but frank bone destruction is a late finding. *Bone scintigraphy* - **Bone scintigraphy** (e.g., technetium-99m) is sensitive for detecting increased bone turnover associated with infection but lacks **specificity**, as it can be positive in other conditions like trauma or tumors. - While it can detect changes earlier than X-rays, typically within 2-3 days, it cannot clearly differentiate infection from other processes, and its spatial resolution is poor compared to MRI.
Explanation: ***Northern blotting*** - **Northern blotting** is a molecular biology technique used to study **gene expression** by detecting specific **RNA molecules** (mRNA) in a sample. - It involves separating RNA fragments by **gel electrophoresis**, transferring them to a membrane, and then detecting specific sequences using **labeled probes**. *Western blotting* - **Western blotting** is a technique used to detect specific **proteins** in a sample. - It involves separating proteins by **gel electrophoresis**, transferring them to a membrane, and then detecting specific proteins using labeled **antibodies**. *Southern blotting* - **Southern blotting** is a molecular biology method used for the detection of **specific DNA sequences** in DNA samples. - It involves separating **DNA fragments** by **gel electrophoresis**, transferring them to a membrane, and then hybridizing with a labeled probe. *Sanger's technique* - **Sanger sequencing**, or the **dideoxy chain-termination method**, is a widely used method for **DNA sequencing**. - It uses **dideoxynucleotides** to terminate DNA synthesis at specific bases, allowing the determination of the **DNA sequence**.
Explanation: ***Gd enhanced MRI*** - **Gadolinium-enhanced MRI** is the investigation of choice for **leptomeningeal carcinomatosis** as it can visualize the subtle nodular or linear enhancement along the leptomeninges, indicating tumor dissemination. - It offers superior **soft tissue contrast** and spatial resolution compared to CT, enabling detection of small lesions and accurate mapping of disease extent. *CT scan* - A **CT scan** has limited sensitivity for detecting leptomeningeal involvement due to poor contrast resolution of soft tissues and the dura/arachnoid spaces. - It might show hydrocephalus or large tumor deposits, but subtle leptomeningeal enhancement is often missed. *SPECT* - **Single photon emission computed tomography (SPECT)** is primarily used for functional imaging and is not the investigation of choice for anatomical visualization of leptomeningeal carcinomatosis. - Its resolution is too low to detect the fine structural changes associated with leptomeningeal spread. *PET* - **Positron emission tomography (PET)**, often combined with CT, identifies metabolically active tumor cells and can detect diffuse metastatic disease. - While useful for overall cancer staging and identifying primary lesions, it is less effective than gadolinium-enhanced MRI for directly visualizing the morphology and enhancement patterns of leptomeningeal carcinomatosis due to limited spatial resolution in the CSF spaces.
Explanation: ***Somatostatin receptor scintigraphy*** - **Somatostatin receptor scintigraphy** is the imaging modality of choice given that most neuroendocrine tumors (NETs) express a high density of somatostatin receptors. - **68Ga-DOTATATE PET/CT** is the **current preferred technique**, offering superior sensitivity (>90%) and specificity compared to older methods like Indium-111 pentetreotide (Octreoscan). - This functional imaging allows for **whole-body evaluation** and can detect both primary tumors and metastases, including small lesions that may be missed on conventional anatomical imaging. - Particularly valuable for detecting occult primary tumors and staging metastatic disease. *USG* - **Ultrasound** is useful for initial screening or evaluating superficial NETs, particularly in organs like the pancreas or liver. - However, its utility is limited by **operator dependence**, gas artifact, and its inability to detect small or deeply located tumors effectively. - Does not provide functional information about somatostatin receptor expression. *CT* - **Computed tomography** provides good anatomical detail and is useful for assessing tumor size, local invasion, and detecting liver metastases. - While helpful for anatomical characterization, CT can **miss small lesions** (especially <1 cm) and does not provide functional information about receptor status. - Often used in combination with functional imaging for treatment planning. *MRI* - **Magnetic resonance imaging** offers excellent soft tissue contrast and is particularly useful for NETs in the liver and pancreas. - Superior to CT for detecting liver metastases due to better soft tissue resolution. - However, MRI has **lower sensitivity for small or widespread lesions** compared to somatostatin receptor imaging and does not provide functional receptor information.
Explanation: ***18F-FDG*** - **18F-FDG (Fluorodeoxyglucose)** is a glucose analog labeled with a **positron-emitting radioisotope**, fluorine-18 (18F). - It is the most commonly used radiotracer in PET scans, as it accumulates in cells with high metabolic activity, particularly **cancer cells** and activated brain cells. *Gadolinium* - **Gadolinium** is a paramagnetic contrast agent primarily used in **MRI scans** to enhance the visualization of blood vessels and abnormal tissues. - It does not emit positrons and is therefore not suitable for PET imaging. *Gastrografin* - **Gastrografin** is an oral, water-soluble contrast agent containing **iodine**, typically used in **X-rays** and **CT scans** of the gastrointestinal tract. - It is not a radioactive tracer and has no application in PET imaging. *Iodine* - **Iodine** in various forms can be used as a contrast agent in **X-rays** and **CT scans**, or as a radioactive isotope (e.g., **I-131**) for **thyroid imaging** and treatment. - While some isotopes of iodine are radioactive, they are not typically used for PET imaging, which relies on positron emission.
Explanation: ***Liver adenoma*** - Tc-labeled RBCs are primarily used to highlight a specific type of tissue or process. **Liver adenomas** do not typically show an affinity for **Tc-labeled RBCs**, as they are benign epithelial tumors with a different vascular composition. - While adenomas can be vascular, they do not inherently contain the **vascular pooling** or blood volume characteristics that would be specifically targeted by **Tc-labeled RBCs** for diagnostic imaging. *LV function* - **Tc-labeled RBCs** (or Tc-99m-pertechnetate) are commonly used in **gated blood pool imaging** (MUGA scan) to assess **left ventricular (LV) function**, including **ejection fraction** and wall motion abnormalities. - This technique directly visualizes the blood pool within the cardiac chambers, making it suitable for assessing functional parameters of the heart. *GI bleeding* - **Tc-labeled RBCs** are a standard imaging agent for detecting and localizing **active gastrointestinal (GI) bleeding**, especially when the bleeding rate is intermittent or slow. - The labeled RBCs extravasate at the site of hemorrhage, creating a 'hot spot' that can be identified over time. *Liver hemangioma* - **Tc-labeled RBCs** are highly effective in diagnosing **liver hemangiomas**, which are benign vascular tumors composed of large, dilated blood vessels. - These lesions show characteristic uptake and retention of **labeled RBCs** due to their slow blood flow and large intravascular space, appearing as early peripheral enhancement with subsequent centripetal filling.
Explanation: ***Plant with Luciferase Gene*** - The plant transformed with the **complete bioluminescent system**, including the **luciferase gene** and **luciferin substrate**, will glow spontaneously because luciferase acts on luciferin to produce light through a chemical reaction. - The question explicitly states "complete Luciferase bioluminescent system (including luciferase gene and luciferin substrate availability)," indicating all necessary components for bioluminescence are present. - **Bioluminescence** is light produced by living organisms through chemical reactions, requiring both enzyme (luciferase) and substrate (luciferin). *Both plants* - This is incorrect because the plant with the **GFP gene** alone will not glow spontaneously in the dark. - GFP requires **excitation by an external light source** (e.g., UV or blue light) to fluoresce, so it cannot contribute to spontaneous glowing. - Only the luciferase-transformed plant produces light spontaneously. *Plant with GFP Gene* - **GFP** (Green Fluorescent Protein) is **fluorescent**, not bioluminescent; it absorbs light at one wavelength and emits it at another wavelength. - GFP does not generate its own light in the dark and requires **illumination with an appropriate light source** (blue or ultraviolet light) to excite the protein and produce visible fluorescence. - Without external light excitation, GFP remains invisible in darkness. *None of the options* - This is incorrect because the plant equipped with a **complete luciferase bioluminescent system** is specifically designed to produce light spontaneously. - All required components (luciferase enzyme and luciferin substrate) are present and functional, enabling autonomous light production in the dark.
Explanation: ***Sulfur colloid scan*** - **Sulfur colloid** is readily phagocytosed by **Kupffer cells** in the liver and spleen, making it useful for evaluating their function. - This scan allows for the assessment of the **reticuloendothelial system's phagocytic activity**, which involves various phagocytes. *MDP scan* - **MDP (methylene diphosphonate)** is used primarily for **bone scans** to detect bone abnormalities, infections, or tumors. - It accumulates in areas of increased **osteoblastic activity**, not phagocytic activity. *Thallium 201* - **Thallium 201** is largely used in **myocardial perfusion imaging** to assess blood flow to the heart muscle. - It acts as a potassium analog and is taken up by viable myocardial cells, not phagocytes. *Technetium pertechnetate scan* - **Technetium pertechnetate** is commonly used for **thyroid scans**, Meckel's diverticulum scans, and brain scans. - It accumulates in glandular tissues with active transport mechanisms involving iodide, and is not involved in phagocyte studies.
Explanation: **A-1, B-4, C-3, D-2** - **Caplan syndrome** was first described in **coal workers** with **rheumatoid arthritis** and progressive massive fibrosis. - **Asbestosis** is often associated with **pleural effusion**, which can be benign or malignant. - **Mesothelioma** typically involves the **lower lobes** of the lungs, specifically the pleura, and is strongly linked to asbestos exposure. - **Sarcoidosis** is characterized by **non-caseating granulomas**, which have a predilection for the **upper lobes** of the lungs. *A-3, B-4, C-2, D-1* - This option incorrectly states that Caplan syndrome involves the lower lobe; **Caplan syndrome** is defined by the presence of large nodules in the lungs of coal workers with rheumatoid arthritis, and their specific lobar distribution is not a defining characteristic. - This option incorrectly states that Mesothelioma has an upper lobe predominance; **Mesothelioma** is a pleural malignancy and typically involves the **lower lobes**, extending along the pleura. *A-4, B-2, C-3, D-1* - This option incorrectly associates Caplan syndrome with pleural effusion; **Caplan syndrome** manifests as rheumatoid nodules in the lungs, not primarily pleural effusion. - This option incorrectly states that Asbestosis has an upper lobe predominance; **Asbestosis** predominantly affects the **lower lobes** of the lungs, causing interstitial fibrosis. *A-2, B-4, C-3, D-1* - This option incorrectly states that Caplan syndrome has an upper lobe predominance; the defining feature of **Caplan syndrome** is the combination of rheumatoid arthritis and pneumoconiosis, not specific lobar involvement. - This option correctly identifies pleural effusion with asbestosis and lower lobe involvement with mesothelioma, but **Caplan syndrome** is not characterized by upper lobe predominance.
Explanation: ***Focal nodular hyperplasia*** - **Focal nodular hyperplasia** (FNH) contains functioning Kupffer cells, which take up **Technetium-99m sulfur colloid** used in nuclear imaging. - FNH typically shows **normal or increased uptake** on sulfur colloid scans, which distinguishes it from other hepatic lesions with high accuracy. - The presence of functional **Kupffer cells and hepatocytes** allows FNH to be diagnosed with high specificity using nuclear imaging. *Cholangiocarcinoma* - **Cholangiocarcinoma** is a malignant tumor of the bile ducts and does not contain Kupffer cells. - It appears as a **photopenic defect** (decreased or absent uptake) on nuclear scans due to its lack of functional liver cells. *Hepatocellular carcinoma* - **Hepatocellular carcinoma** (HCC) is a primary liver malignancy that typically lacks functional Kupffer cells. - HCC usually shows **decreased or absent uptake** on **Technetium-99m sulfur colloid scans**, appearing as a cold lesion. *Hepatic adenoma* - A **hepatic adenoma** is a benign liver tumor that lacks Kupffer cells and thus does not take up the tracer in nuclear imaging. - Adenomas appear as **photopenic defects** on sulfur colloid scans and are better characterized by their enhancement patterns on MRI or CT.
Get full access to all questions, explanations, and performance tracking.
Start For Free